NFE2L2 and diabetic cardiomyopathy: Indeed, SFN prevents myocardial ischemia-reperfusion injury [28], diabetic cardiomyopathy and nephropathy [29], and Ang II-induced cardiomyopathy by upregulating Nrf2 [25].